Gemin X Pharmaceuticals
Latest round
- Series E
Last raised
- Aug 2010
Total raised
- $62M
Investors
- 13
About Gemin X Pharmaceuticals
Gemin X Pharmaceuticals Inc.Gemin X Pharmaceuticals Inc. was founded in 1998 in Montreal, Canada, and specializes in the development of novel cancer therapies. The company was acquired by Cephalon in March 2011 for USD 225 mn. Throughout its operations, Gemin X has completed a total of 5 deals, with the most recent deal occurring on March 21, 2011.Gemin X Pharmaceuticals Inc. specializes in developing advanced biopharmaceutical products aimed at treating cancer. Their core offerings include targeted therapies designed to optimize patient treatment regimens, specifically addressing various types of oncology-related conditions.Gemin X Pharmaceuticals Inc. generates revenue primarily through the sale of its oncology-focused product portfolios, which are marketed directly to healthcare providers. The company has established partnerships that allow for customized implementation of its therapies, enhancing their value proposition to healthcare clients.In the wake of its acquisition by Cephalon, Gemin X Pharmaceuticals plans to leverage the synergies from this partnership to expand its product offerings into additional cancer therapies. The company is currently exploring new formulations and treatment protocols for launch within the next two years. Additionally, Gemin X aims to penetrate markets in Europe and Asia by 2025, capitalizing on its innovative product pipeline.
Who invested in Gemin X Pharmaceuticals
13 investors across 3 rounds
See all investors in Gemin X Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gemin X Pharmaceuticals
Who invested in Gemin X Pharmaceuticals?
Gemin X Pharmaceuticals has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gemin X Pharmaceuticals raised?
Gemin X Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gemin X Pharmaceuticals last raise money?
Gemin X Pharmaceuticals's most recent round on record is a Series E, in Aug 2010.
What does Gemin X Pharmaceuticals do?
Gemin X Pharmaceuticals is a pharmaceuticals company.
Where is Gemin X Pharmaceuticals headquartered?
Gemin X Pharmaceuticals is headquartered in Montreal, Canada.
Which VCs invest in companies like Gemin X Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Gemin X Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Gemin X Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.